The initial partnership between the two firms was established in 2018. Since then, Symphogen has been using Thermo Fisher's Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry system with BioPharma, as well as Thermo Fisher's Thermo Scientific Orbitrap Exploris 480 mass spectrometer to develop and test therapeutic monoclonal antibody drugs.

Symphogen also uses Thermo Fisher's Thermo Scientific Orbitrap Fusion Tribrid mass spectrometer and its Vanquish ultrahigh-performance liquid chromatography systems and its Chromeleon chromatography data system software, Thermo Fisher Scientific said.

Thermo Fisher expands Direct-to-Patient clinical trial service
Thermo Fisher Scientific said it has expanded its Direct-to-Patient clinical trial service to enable clinical trial medications to be delivered directly...

Thermo Fisher's Q3 earnings boosted by COVID-19 sales
Products related to the novel coronavirus are spelling success for Thermo Fisher, which reported that revenue was up by 36% in the third quarter to $8.52 billion,...

Thermo Fisher launches closed cell processing system
Thermo Fisher Scientific has launched the Gibco CTS Rotea counterflow centrifugation system, a modular, closed cell therapy processing system for cell...

Thermo Fisher to add sterile filling lines in Singapore
Thermo Fisher Scientific will operate a $130 million facility in Singapore that will be used to develop two new sterile filling lines, extending...

Thermo Fisher debuts clinical research grant program
Thermo Fisher Scientific introduced a clinical research grant program to support health projects in oncology and reproductive health.